Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Artery Stenosis in Coronary Artery Disease: Medical Therapy Versus Medical Therapy Plus Renal Artery Stenting in Preventing Cardiac and Renal Outcomes. The Rationale and Study Design of a Prospective,Randomized Trial: the RASCAD Study

NCT01173666 is registered in ClinicalTrials.gov with Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele as lead sponsor.

NCT NCT01173666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01173666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Artery Stenosis in Coronary Artery Disease: Medical Therapy Versus Medical Therapy Plus Renal Artery Stenting in Preventing Cardiac and Renal Outcomes. The Rationale and Study Design of a Prospective,Randomized Trial: the RASCAD Study
Lead sponsor
Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2006
Completion date
April 30, 2011
Enrollment
168 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular hypertrophy, renal artery stenosis